Bardan Ahmed Shalaby, Lee Hanbin, Nanavaty Mayank A
J Refract Surg. 2018 Oct 1;34(10):690-696. doi: 10.3928/1081597X-20180824-01.
To evaluate the outcomes of simultaneous and sequential corneal crosslinking (CXL) and excimer laser surface ablation protocols in keratoconus.
A literature review was conducted using MEDLINE. The studies were divided into three groups: the sequential group included studies with CXL followed by excimer laser surface ablation later, the simultaneous group included simultaneous excimer laser surface ablation and CXL, and the no CXL group included excimer laser surface ablation only with no CXL. The data on change in logMAR uncorrected distance visual acuity (UDVA), spectacle corrected distance visual acuity (CDVA), change in spherical equivalent (SE) and refractive astigmatism, change in maximum keratometry (Kmax), complications, and safety and efficacy indices were presented for the latest follow-up visits in all groups.
Twenty-one studies (3 = sequential; 11 = simultaneous, 7 = no CXL) were included. UDVA improved in all groups. CDVA improved more in the sequential group. SE change was greatest in the no CXL group and the refractive astigmatism reduced comparably in the sequential and no CXL groups but less in the simultaneous group. Kmax reduced in all groups. Only the sequential group showed no progression. Corneal haze was reported in 100%, 54.5%, and 57.1% studies, respectively. Safety and efficacy indices were 1.96 and 1.58, 1.41 ± 0.32 and 0.91 ± 0.41, and 1 and 0.82, respectively.
The sequential group showed greater improvement in CDVA, SE, and refractive astigmatism. Corneal haze was frequently reported in all protocols. Safety and efficacy indices were highest when CXL was performed before excimer laser and least when excimer laser was performed alone without CXL. [J Refract Surg. 2018;34(10):690-696.].
评估圆锥角膜患者同时和序贯角膜交联(CXL)与准分子激光表面切削方案的治疗效果。
使用MEDLINE进行文献综述。研究分为三组:序贯组包括先进行CXL随后再行准分子激光表面切削的研究;同时组包括准分子激光表面切削与CXL同时进行的研究;无CXL组包括仅行准分子激光表面切削而未进行CXL的研究。列出了所有组最后一次随访时未矫正远视力(UDVA)的对数最小分辨角(logMAR)变化、眼镜矫正远视力(CDVA)、等效球镜度(SE)变化、屈光性散光、最大角膜曲率(Kmax)变化、并发症以及安全性和有效性指标的数据。
纳入21项研究(3项序贯组;11项同时组,7项无CXL组)。所有组的UDVA均有改善。序贯组的CDVA改善更明显。无CXL组的SE变化最大,序贯组和无CXL组的屈光性散光降低程度相当,但同时组降低程度较小。所有组的Kmax均降低。只有序贯组显示无进展。分别有100%、54.5%和57.1%的研究报告了角膜 haze。安全性和有效性指标分别为1.96和1.58、1.41±0.32和0.91±0.41,以及1和0.82。
序贯组在CDVA、SE和屈光性散光方面改善更大。所有方案中均频繁报告角膜 haze。当在准分子激光治疗前进行CXL时,安全性和有效性指标最高,而仅行准分子激光治疗而未进行CXL时最低。[《屈光手术杂志》。2018;34(10):690 - 696。]